Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, March 15 '25)

Image
By G.M.

 


    Am J Obstet Gynecol

  1. TAN YY, Loy EXH, Tan WZ, Tay AT, et al
    Long COVID-19 in pregnancy: increased risk but modest incidence following mild Omicron infection in a boosted obstetric cohort during endemicity.
    Am J Obstet Gynecol. 2025 Mar 10:S0002-9378(25)00147.
    PubMed         Abstract available


    BMJ

  2. IACOBUCCI G
    Covid-19: Gove tried to "circumvent" regulations to buy Dyson ventilators, inquiry hears.
    BMJ. 2025;388:r502.
    PubMed        


    Clin Infect Dis

  3. BARTOLETTI M, Mozaffari E, Amin AN, Doi Y, et al
    A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence?
    Clin Infect Dis. 2025 Mar 11:ciaf111. doi: 10.1093.
    PubMed         Abstract available

  4. COX SN, Roychoudhury P, Frivold C, Acker Z, et al
    Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023.
    Clin Infect Dis. 2025 Mar 14:ciaf048. doi: 10.1093.
    PubMed         Abstract available

  5. KELLY JD, Hoggatt KJ, Lo NC, Leonard S, et al
    Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunity.
    Clin Infect Dis. 2025 Mar 14:ciaf124. doi: 10.1093.
    PubMed         Abstract available

  6. ROCKSTROH JK, Paredes R, Cahn P, Molina JM, et al
    Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial.
    Clin Infect Dis. 2025 Mar 13:ciaf077. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  7. LI Z, Wang Z, Wang X, Chen S, et al
    Global containment policy duration and long-term epidemic progression: a target trial emulation using COVID-19 data from 2020 to 2022.
    Int J Infect Dis. 2025 Mar 5:107871. doi: 10.1016/j.ijid.2025.107871.
    PubMed         Abstract available

  8. MADEWELL ZJ, Wong JM, Thayer MB, Rivera-Amill V, et al
    Population-level respiratory virus-virus interactions, Puerto Rico, 2013-2023.
    Int J Infect Dis. 2025 Mar 11:107878. doi: 10.1016/j.ijid.2025.107878.
    PubMed         Abstract available


    J Infect

  9. WARD T, Paton RS, Overton CE, Mellor J, et al
    Understanding the Effectiveness of the Comirnaty Monovalent and Bivalent Vaccines During the Winter Coronavirus (COVID-19) Infection Survey.
    J Infect. 2025 Mar 5:106461. doi: 10.1016/j.jinf.2025.106461.
    PubMed         Abstract available


    J Med Virol

  10. AZANZA JR, Gonzalez Del Castillo JM, Ferrando R, Molero JM, et al
    Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain.
    J Med Virol. 2025;97:e70288.
    PubMed         Abstract available

  11. LIU S, Liu P, Lu Q, Shen Y, et al
    The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS-CoV-2 Omicron Variants.
    J Med Virol. 2025;97:e70242.
    PubMed         Abstract available

  12. GARCIA-VIDAL C, Teijon-Lumbreras C, Aiello TF, Chumbita M, et al
    COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach.
    J Med Virol. 2025;97:e70276.
    PubMed         Abstract available


    JAMA

  13. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed        


    Lancet

  14. SINGH B, Lipunga GD, Thangavelu P, Dhar S, et al
    A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.
    Lancet. 2025 Mar 10:S0140-6736(25)00263-6. doi: 10.1016/S0140-6736(25)00263.
    PubMed         Abstract available

  15. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed         Abstract available


    Nature

  16. GOETZKE CC, Massoud M, Frischbutter S, Guerra GM, et al
    TGFbeta links EBV to multisystem inflammatory syndrome in children.
    Nature. 2025 Mar 12. doi: 10.1038/s41586-025-08697.
    PubMed         Abstract available

  17. CALLAWAY E
    Four ways COVID changed virology: lessons from the most sequenced virus of all time.
    Nature. 2025;639:293-295.
    PubMed        


  18. Immune molecule links COVID?19 with severe inflammatory disorder in children.
    Nature. 2025 Mar 12. doi: 10.1038/d41586-025-00735.
    PubMed        


    Pol J Radiol

  19. HAJSADEGHI S, Kasaei M, Pouraliakbar H, Jamalkhani S, et al
    Comparing myocardial injury patterns and outcomes in cardiac magnetic resonance imaging between COVID-19- and non-COVID-19-related myocarditis.
    Pol J Radiol. 2025;90:e36-e45.
    PubMed         Abstract available


    Science

  20. WADMAN M
    No sign that vaccine advisers are beholden to industry.
    Science. 2025;387:1131-1132.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »